Ice cream makers have begun to adjust recipes and portion sizes in response to the spread of GLP-1 weight-loss drugs and the growing demand for lower-calorie products. Companies are adding more protein, simplifying ingredients and releasing smaller portions to adapt to consumers’ new eating habits.
Despite the hot summer that traditionally promotes ice cream sales, manufacturers are already noticing changes in the market, according to Reuters. According to NielsenIQ, ice cream sales in the United States fell by 1.5% in the first half of June compared to last year.
One reason is the spread of GLP-1 drugs, which suppress appetite and are used, in particular, for weight loss. According to estimates by the Boston Consulting Group, about 16 million Americans take such drugs. The company’s research showed that their users consume at least 10% fewer frozen desserts.
At the same time, manufacturers do not expect people to completely abandon ice cream. Instead, they are counting on demand for desserts with fewer calories, more protein, and simpler ingredients.
Major ice cream makers are already expanding their ranges to include lower-calorie desserts, higher-protein options, and no-added-sugar options. The companies say demand for such options is growing, particularly among people taking GLP-1 drugs.
At the same time, manufacturers are reducing portion sizes and reviewing product ingredients. High-fructose corn syrup, artificial colors, and flavors are being phased out of recipes as consumers become more aware of the ingredients in their ice cream.
The trend is spreading beyond the United States. In Europe, manufacturers are also seeing a rise in demand for smaller portions, higher-quality premium ice cream, and lower-calorie frozen desserts.
The industry says that the rise of GLP-1 drugs means people can indulge in sweets less often. Still, they are also becoming more discerning about their taste and quality.